TritonPoint Partners »

Vertex Pharmaceuticals Incorporated shares owned by TritonPoint Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by TritonPoint Partners from 13F filings

Historical chart of TritonPoint Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by TritonPoint Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by TritonPoint Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $351k 706 496.73

More positions owned by TritonPoint Partners

Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Vanguard Index Fds Growth Etf (VUG)
Lam Research Corp Com New (LRCX)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr U.s. Tech Etf (IYW)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Xpo Logistics Inc equity (XPO)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for TritonPoint Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated